<?xml version="1.0" encoding="UTF-8"?>
<p id="p0045">For the second target-SARS-CoV M
 <sup>pro</sup>, the top 5 lead molecules identified were Saquinavir (ZINC000026985532), Ergotamine (ZINC000052955754), Nilotinib (ZINC000006716957), Raltegravir (ZINC000013831130) and Dihydroergotamine (ZINC000003978005) with binding energies of −9.6 kcal/mol, −9.5 kcal/mol, −9.4 kcal/mol, −9.2 kcal/mol and −9.2 kcal/mol respectively (
 <xref rid="t0010" ref-type="table">Table 2</xref>). The best lead molecule- Saquinavir (ZINC000026985532) exhibits four hydrogen bonds (Three bonds with the backbone nitrogen (N) and oxygen (O) atom of Gly143, Leu141 and Glu166 and one hydrogen bond with side-chain oxygen (OE1) atom of Gln189) and twelve residues (Thr25, Thr26, His41, Met49, Phe140, Asn142, Cys145, His164, Met165, Leu167, Thr190 and Gln192) contributing to hydrophobic interactions with the target enzyme (
 <xref rid="f0010" ref-type="fig">Fig. 2</xref>A). The control, inhibitor SG85 (G85) of SARS-CoV M
 <sup>pro</sup> exhibits binding energy of −7.9 kcal/mol with four hydrogen bonds (two hydrogen bonds with backbone N atoms of Cys145 and Glu166 and two hydrogen bonds with the side chain sulphur (SG) atom of Cys145 and side-chain oxygen (OE1) atom of Gln189) and hydrophobic interactions via sixteen residues (Thr25, Thr26, His41, Met49, Phe140, Leu141, Asn142, Gly143, Ser144, His163, His164, Met165, Asp187, Thr190, Ala191 and Gln192) (
 <xref rid="f0010" ref-type="fig">Fig. 2</xref>B).
</p>
